BeStock  

AstraZeneca AZN

US equityMarket cap rank #49Infectious Disease
$186.43 −$0.42 (-0.22%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $185.92 -0.27%
Open$181.34
Prev close$186.85
Day range$181.20 – $187.33
Volume2.85M
Market cap$289.14B
P/E (TTM)26.4
Dividend yield1.73%

Analyst view

ConsensusBuy
Analysts14
Average target$219.53+17.8% vs. price
  • Buy 86%
  • Hold 7%
  • Sell 7%
Low $155.10Now $186.43Avg $219.53High $273.82

Recent rating changes

The last 20 actions on file set price targets from $193.43 to $273.82, averaging $223.89.

DateFirmRatingTarget
3 Nov 2026 Bernstein BUY $273.82
3 Nov 2026 DZ BANK AG BUY –
3 Nov 2026 Jefferies BUY $233.75
3 Nov 2026 Goldman Sachs BUY $234.82
2 Nov 2026 UBS BUY $213.71
2 Nov 2026 Citi BUY $252.45
2 Nov 2026 Barclays BUY $227.07
2 Nov 2026 RBC Capital BUY $203.69
30 Oct 2026 Bernstein BUY $265.34
30 Oct 2026 UBS BUY $203.49
30 Oct 2026 BofA Securities BUY –
27 Oct 2026 Jefferies BUY $234.52
27 Oct 2026 Citi BUY –
27 Oct 2026 RBC Capital BUY $194.12
26 Oct 2026 Barclays BUY $214.20
26 Oct 2026 J.P. Morgan BUY $213.71
21 Oct 2026 J.P. Morgan BUY $214.15
20 Oct 2026 Jefferies BUY $233.45
20 Oct 2026 RBC Capital BUY $193.43
16 Oct 2026 Berenberg Bank BUY $200.36

Discussion

No comments yet — be the first to weigh in on AZN.

Sign in to join the discussion.

Scroll to Top